explore -WSS

explore

author：focus 2025-09-06 02:03:41 - browse：281

An light blue number 3 with an eye is surrounded by smaller, black number 3s on an orange background — 3 to watch coverage from STAT — Christine Kao/STAT

It’s been a slow year for medtech. Major deals in 2023 were scarce, funding was hard to come by, and valuations were down. On the policy side, the industry grappled with changing AI regulations, reimbursement woes, and device sterilization rules.

Here are three political and market forces that shaped the medtech industry last year, and are worth paying attention to in 2024:

Lobbying power of AI, software-enabled devices

Medtech lobby AdvaMed announced earlier this month that the major medical imaging companies, previously housed within the National Electrical Manufacturers Association, were shifting to their shop. The device group also created a separate niche for digital health companies in October.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： UnitedHealth wins $3.3 billion takeover of Amedisys

Wikipedia

WSS

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Here's how to stay safe from wildfire smoke amid reduced air quality

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Lecanemab for Alzheimer's is coming. Is the health system ready?

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Leqembi, other new Alzheimer’s drugs require better biomarkers

knowledge

explore

Lobbying power of AI, software-enabled devices

focus

Drug repurposing or repositioning? The language matters

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Alkermes shareholders re

The simple reason for the increase in autism diagnosis

Tori Bowie and the unacceptable rates of Black maternal death

Medical experts exlpore how to eliminate bias in clinical algorithms

Hepatitis C has a cure — but many Americans still lack access to it

GOP inquiry over gain

Activists slam private health insurers over coverage restrictions

Leqembi, other new Alzheimer’s drugs require better biomarkers

focus

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

New research casts further doubt on a common procedure used with IVF

Retired US general questions alleged Putin, Prigozhin meeting

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

What to know about OceanGate, the company behind the missing Titanic submersible

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

explore

Wikipedia

hotspot

explore